Moderna
MRNA
#290
Rank
NZ$144.23 B
Marketcap
NZ$356.46
Share price
-2.17%
Change (1 day)
724.34%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2026 (TTM): -NZ$5.3 Billion

According to Moderna 's latest financial reports the company's current earnings are NZ$2.21 Billion. In 2025 the company made an earning of -NZ$5.05 Billion, an increase over its 2024 earnings that were of -NZ$6.55 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$5.3 Billion5.08%
2025 -NZ$5.05 Billion-23.03%
2024 -NZ$6.55 Billion-8.22%
2023 -NZ$7.14 Billion-140.65%
2022 NZ$17.55 B-27.81%
2021 NZ$24.31 B-1911.15%
2020 -NZ$1.35 Billion44.7%
2019 -NZ$0.93 Billion28.63%
2018 -NZ$0.73 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.22 B-714.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$23.11 B-515.21%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
NZ$12.28 B-320.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-NZ$86.71 Million-98.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.22 Billion-96.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-NZ$76.35 Million-98.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
NZ$2.23 B-140.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-NZ$0.3 Billion-94.76%๐Ÿ‡บ๐Ÿ‡ธ USA